QUINAPRIL REDUCES MICROALBUMINURIA IN ESSENTIAL HYPERTENSIVE AND IN DIABETIC HYPERTENSIVE SUBJECTS

被引:16
作者
DOMINGUEZ, LJ
BARBAGALLO, M
KATTAH, W
GARCIA, D
SOWERS, JR
机构
[1] Servicio de Endocrinologla, Hospital de San José, Bogota
[2] Division of Endocrinology and Hypertension, Wayne State University, Detroit, MI
关键词
ANGIOTENSIN CONVERTING ENZYME INHIBITORS; QUINAPRIL; HYPERTENSION; DIABETES; INSULIN RESISTANCE; MICROALBUMINURIA;
D O I
10.1016/0895-7061(95)00143-D
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To investigate the metabolic and renal effects of the nonsulfhydryl, tissue-active ACE inhibitor quinapril in diabetes and in hypertension, we studied 30 essential hypertensives and 24 non-insulin-dependent (type II) diabetic (NIDDM) subjects with hypertension. Systolic and diastolic blood pressures, plasma glucose, and insulin responses to an oral glucose load (75 g), lipid profile, and urinary albumin excretion were evaluated before and after 8 weeks' administration of quinapril (10 to 40 mg/day). Quinapril produced a significant and comparable reduction of arterial blood pressure in both groups. Mean arterial pressure decreased from 114.8 +/- 0.9 to 94.2 +/- 1.1 (-17.9 +/- 1.5%) in the essential hypertensive group and from 118.4 +/- 1.6 to 96.2 +/- 1.4 (-18.4 +/- 1.6%) in the diabetic hypertensive group. In both essential hypertensives and diabetic-hypertensive subjects with microalbuminuria, quinapril significantly and comparably reduced the urinary albumin excretion rate (UAE); UAE decreased from 32.5 +/- 5.5 mu g/min to 14.7 +/- 3.7 mu g/min min (P < .05 v baseline) in the diabetic-hypertensive group and from 27.5 +/- 3.0 mu g/min to 11.6 +/- 2.7 mu g/min (P < .05 v baseline) in the essential hypertensives. Altogether, a direct correlation was found between the initial level of UAE and the UAE reduction after quinapril (Delta UAE) (r = 0.706, p < .05). Insulin and glucose responses to an oral glucose tolerance test and the lipid profiles were not modified by quinapril treatment. The results confirm that quinapril is an effective antihypertensive agent that additionally reduces microalbuminuria in both hypertensive diabetics and in patients with essential hypertension, without altering insulin sensitivity and lipid profiles.
引用
收藏
页码:808 / 814
页数:7
相关论文
共 39 条
  • [1] Viberti, Hill, Jarret, Et al., Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus, Lancet, 1, pp. 1430-1432, (1982)
  • [2] Mogensen, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes, N Engl J Med, 310, pp. 356-360, (1984)
  • [3] Bigazzi, Bianchi, Campese, Baldari, Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension, Nephron, 61, pp. 94-97, (1992)
  • [4] Mattock, Morrish, Viberti, Et al., Prospective study of microalbuminuria as predictor of mortality in NIDDM, Diabetes, 41, pp. 736-741, (1992)
  • [5] Yudkin, Forrest, Jackson, Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey, Lancet, 2, pp. 530-533, (1988)
  • [6] Haffner, Stern, Gruber, Et al., Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects?, Arteriosclerosis, 10, pp. 727-731, (1990)
  • [7] Lewis, Hunsicher, Bain, Rhode, The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, pp. 1456-1462, (1993)
  • [8] Kasiske, Kalil, Ma, Et al., Effect of antihypertensive therapy on the kidney in patients with diabetes a meta-regression analysis, Annals of Internal Medicine, 118, pp. 129-138, (1993)
  • [9] Bianchi, Bigazzi, Baldari, Campese, Microalbuminuria in patients with essential hypertension: effects of several hypertensive drugs, Am J Med, 93, pp. 525-528, (1992)
  • [10] Jarret, Keen, McCartney, Et al., Glucose tolerance and blood pressure in two population samples their relationship to diabetes mellitus and hypertension, International Journal of Epidemiology, 7, pp. 15-24, (1978)